TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Novo Nordisk Pharma Operations A/S
Closing information (x1000 SEK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
135,643
|
106,855
|
113,199 |
Earnings before taxes |
6,048
|
5,037
|
5,404 |
Total assets |
97,451
|
73,771
|
78,104 |
Current assets |
82,297
|
65,477
|
61,791 |
Current liabilities |
58,439
|
49,653
|
53,422 |
Equity capital |
28,245
|
23,454
|
20,070 |
- share capital |
688
|
675
|
698 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
29.0%
|
31.8%
|
25.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.5%
|
4.7%
|
4.8% |
Return on assets (ROA) | |||
Current ratio |
140.8%
|
131.9%
|
115.7% |
Return on equity (ROE) |
21.4%
|
21.5%
|
26.9% |
Change turnover |
26,726
|
-2,489
|
27,490 |
Change turnover % |
25%
|
-2%
|
32% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.